WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS 3 4 2]
CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2012
[FORM 10-Q (Mark One) x June 30, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86- 898-6681-1730 (China)] [CERTIFICATION OF OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 14, 2012 President and Chief Executive Officer cphi10qex321063012.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 14, 2012 (principal financial officer and principal accounting officer) cphi10qex322063012.htm 5 EX-32.2]
CEO [CNOOC] 6-K: CNOOC Limited
[CNOOC Limited]
KNDI [Kandi Technologies] 10-Q: FORM 10-Q June 30, 2012 For the quarterly
[FORM 10-Q June 30, 2012 For the quarterly period ended or [ ] For the transition period from _________ to _________ 001-33997 KANDI TECHNOLOGIES, CORP. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Jinhua City Industrial Zone Jinhua, Zhejiang Province Peoples Republic of China Post Code 321016 (86 - 579) 82239856 Yes [X] No] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS 3 4 2
[Form 6-K TABLE OF CONTENTS 3 4 2]
CNET [ChinaNet Onlines,] NT 10-Q: (Original Filing)
[PART III State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof,uld not be filed within the prescribed time period. PART IV (1) Name and telephone number of person tontact in regard to this notification Lawrence Venick]
CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)
[99 China Jo-Jo Drugstores, Inc. Reports Fiscal First Quarter 2013 Revenue and Schedules First Quarter FY 2013 Conference Call Business Wire HANGZHOU, China -- August 14, 2012 China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the first quarter of fiscal 2013]
CREG [CHINA RECYCLING ENERGY] 10-Q: (Original Filing)
[] [First AMENDMENT TO CONVERTIBLE PROMISSORY NOTE TRANSFER AGREEMENT th This First Amendment to the Convertible Promissory Note Transfer Agreement is executed on this 24 WHEREAS WHEREAS WHEREAS WHEREAS, NOW THEREFORE Section 1.01. The Note Transfer 1. 2. (1) Section 2.01 (e) will be deleted in its entirety and replaced with the following: (2) Section 2.01 (h) will be deleted in] [CERTIFICATIONS I, Guohua Ku, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, David Chong, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. August 14, 2012 Guohua Ku Chairman of the Board and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. August 14, 2012 David Chong Chief Financial Officer and Secretary]
CNET [ChinaNet Onlines,] NT 10-Q: PART III State below in reasonable detail the
[PART III State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof,uld not be filed within the prescribed time period. PART IV (1) Name and telephone number of person tontact in regard to this notification Lawrence Venick]
CJJD [CHINA JO-JO DRUGSTORES] 8-K: 99 China Jo-Jo Drugstores, Inc. Reports Fiscal First
[99 China Jo-Jo Drugstores, Inc. Reports Fiscal First Quarter 2013 Revenue and Schedules First Quarter FY 2013 Conference Call Business Wire HANGZHOU, China -- August 14, 2012 China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the first quarter of fiscal 2013]
